Chronic Disease Management Market Size, Growth and Share Analysis By Solution (Educational Solution, Implementation Solution, Consulting Solution and others), Delivery Mode (Cloud-Based, On-Premises and Web-Based), Application (Arthritis, Cardiovascular Disease, Cancer, Diabetes and others), End-User (Providers, Payers) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) – Forecast till 2025
Chronic Disease Management Market Scope
MRFR (Market Research Future) expects the chronic disease management market size to grow at a significant CAGR of 14.5% between 2019 and 2025 (projection period). We will provide COVID-19 impact analysis with the report, along with all the notable developments following the coronavirus disease outbreak.
Chronic diseases are some of the major concerns among the elderly population, who are more susceptible to obesity, diabetes and such. The constantly expanding middle class populace along with the surge in the urbanization rate across the world also adds to the chances of chronic diseases, since these factors are in conjunction with a sedentary and an inactive lifestyle. Therefore, cases of obesity and diabetes have been rising exponentially, not only among the older population but also among the youth. The healthcare sector also provides preventive health services along with patient-centric care, which opens the doors for retail, telecommunications, technology and wellness and fitness segments to introduce innovative solutions pertaining to chronic disease management market.
Request Free Sample Copy of the report “ Chronic Diseases Management Market Report- Forecast to 2025” at: https://www.marketresearchfuture.com/sample_request/981
The IT healthcare services and advanced digital health technologies have gathered a lot of traction in recent years, proving to be instrumental in the growth of the chronic disease management industry. The chronic disease management market gets further boost form the increased adoption of health information technologies and the various online resource options available in healthcare. Studies confirm that in 2015, close to 36 million patients leveraged the Medicare reimbursement policy for chronic disease management services. Intense rivalry between top services providers in the market is observed, which prompts these players to come up with a variety of schemes that draw in a higher number of consumers.
Chronic disease management has been gaining significantly on the back of growing adoption of health information-based technologies as well as online healthcare platforms. The market is characterized by a high number of partnerships, collaborations and acquisitions between healthcare firms and leading firms, which also enhance the market size. For instance, in October 2020, Aetna partnered with Landmark Health to use home healthcare for addressing chronic disease management. The partnership will allow the patients to be safe at home and aim to offer effective treatment for chronic conditions.
COVID-19 Impact on Chronic Disease Management Market
The latest study on the hospitalized patients affected by SARS-CoV-2 in the United States suggests that advanced EHR systems were used to conclude that diabetes, obesity and hypertension are the primary chronic diseases gaining traction since the pandemic. Out of the 2,634 patients, 41.7 percent had obesity, 33.8 percent had diabetes and 56.6 percent had hypertension. England’s Department of Health and Social Care reveals that the patient pool currently receiving treatment for chronic diseases comes close to 70% of the overall health and social care spending.
However, majority of the funding and resources has been allocated for the control of the novel coronavirus pandemic, which is still uncontrollable despite the worldwide lockdown. This factor is delaying the treatment of individuals affected by chronic diseases. However, the COVID-19 outbreak has boosted the use of various digital platforms that help people gain improved access to medical care, which can be favorable for the care management market and boost the demand for chronic disease management solutions.
Chronic Disease Management Market Segmental Outlook
The chronic disease management market has been categorized depending on solution, delivery mode, application, and end user.
The solutions covered in the extensive chronic disease management market study include consulting solution, educational solution and implementation solution, among others.
The significant applications of chronic disease management market are safety arthritis, cardiovascular disease, cancer, diabetes, and others.
On-premises along with web-based and cloud-based are some of the key delivery modes analyzed in the chronic disease management market report.
Payers, providers, and others are the prominent end-users in the worldwide chronic disease management market.
Chronic Disease Management Market Regional Insight
The MRFR report has studied the chronic disease management market size and its expected growth rate across the key regions of Europe, MEA/Middle East & Africa, the Americas and APAC/Asia Pacific.
The Americas could be the highest gainer in the global chronic disease management market during the conjectured period, thanks to the heightened demand for chronic disease management in view of the surging cases of diabetes, cancer and more along with the significant funds allocated for research and development/R&D for biotech and pharma companies. The United States is home to the top 10 chronic care management companies in the world, such as ScienceSoft USA Corporation and Allscripts Healthcare Solutions Inc., which also works in the market’s favor.
Europe is touted to be the second leading chronic disease management market in the near future, considering the dramatic growth in health-related complications among people and the rapidly expanding geriatric population. These aspects are boosting the spending levels on advanced healthcare services, plus the government is also developing policies that promote the use of advanced solutions such as chronic disease management in healthcare.
APAC chronic disease management market will be racing ahead at the fastest speed over the coming years, on account of the booming population combined with the rampant demand for innovative and effective treatments and services. The discerning surge in cancer cases in the developing countries of Japan, Hong Kong and India is leading the regional market to greater heights. The rising trend of medical tourism in the region and the promising growth of healthcare IT also benefit the chronic condition management market in Asia Pacific.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/chronic-disease-management-market-981
Chronic Disease Management Market Top Firms
The top firms profiled in the chronic disease management market report are TriZetto Corporation (US), EXL Healthcare (New York), Infosys Limited (India), Pegasystems Inc. (US), ScienceSoft USA Corporation (US), Allscripts Healthcare Solutions Inc. (US), Harmony Information Systems, Inc.(US), Koninklijke Philips NV (Netherlands), MINES & Associates Inc. (US), Siemens Healthcare Private Limited (Germany), and more.
Browse More Related Research Reports at:
- The Global Tissue Engineering Market size is likely to touch USD 53,424 million at a whopping 17.84% CAGR between 2016- 2024
- The global immunotherapy drugs market size is expected to exhibit a strong 8.9% CAGR over the forecast period from 2018 to 2023
- A CAGR 20.2% is predicted to bolster the expansion of the aptamers market in the coming period
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312